Cor Vasa 2026, 68(2):201-205 | DOI: 10.33678/cor.2025.128

Cardiovascular Bypass Surgery: Contemporary Strategies for Postoperative Cardiac Follow-Up

Gökhan Ceyhun
Department of Cardiology, Faculty of Medicine, Atatürk University, Erzurum, Turkey

Coronary artery bypass grafting (CABG) remains the cornerstone surgical therapy for complex or advanced coronary artery disease. Yet, the long-term success of CABG depends heavily on systematic postoperative cardiac follow-up. Early evaluation focuses on arrhythmia prevention, hemodynamic stability, and detection of perioperative myocardial injury, whereas long-term care integrates graft surveillance, risk-factor modification, and rehabilitation. New data highlight biomarkers such as NT-proBNP, galectin-3, and adropin, together with imaging modalities like strain echocardiography and cardiac CT angiography. A multidisciplinary, patient-centered model ensures better outcomes and quality of life after CABG.

Keywords: Biomarkers, Cardiac rehabilitation, Coronary artery bypass grafting, Graft patency, Postoperative monitoring

Received: October 6, 2025; Revised: November 30, 2025; Accepted: December 3, 2025; Prepublished online: June 2, 2012; Published: May 20, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ceyhun G. Cardiovascular Bypass Surgery: Contemporary Strategies for Postoperative Cardiac Follow-Up. Cor Vasa. 2026;68(2):201-205. doi: 10.33678/cor.2025.128.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Devereaux PJ, Lamy A, Chan MT, et al. High-sensitivity troponin I after cardiac surgery and 30-day mortality. N Engl J Med 2022;386:827-836. Go to original source...
    2. Niccoli G, Conte M, Marchitti S, et al. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation. Cardiovasc Revasc Med 2016;17:162-168. Go to original source... Go to PubMed...
    3. Ho JE, Liu C, Lyass A, et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol 2012;60:1249-1256. Go to original source... Go to PubMed...
    4. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227-3337. Go to original source... Go to PubMed...
    5. Gong Y, Jeong YH, Wang TD, et al. Position Statement on Antiplatelet Therapy for East Asians with Coronary Artery Disease: 2025 Update. JACC: Asia 2025;5:821-846. Go to original source...
    6. Kurlansky P, Herbert M, Prince S, et al. Coronary Artery Revascularization Evaluation-A Multicenter Registry with Seven Years of Follow-Up. J Am Heart Assoc 2013;2:e000162. Go to original source... Go to PubMed...
    7. Agrawal A, Kumar A, Majid M, et al. Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis. Heart 2024;110:323-330. Go to original source...
    8. Carvalheira-Dos-Santos R, Delgado RM, Ferreira-Dos-Santos G, Vaz-Carneiro A. Análise da Revisão Cochrane: Reabilitação Cardíaca Baseada no Exercício na Doença Arterial Coronária. Cochrane Database Syst Rev 2016;1:CD001800 [Analysis of the Cochrane Review: Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease. Cochrane Database Syst Rev 2016;1:CD001800]. Acta Med Port 2019;32:483-487. Portuguese. Go to original source... Go to PubMed...
    9. Schuuring MJ, Treskes RW, Castiello T, et al. Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum. Eur Heart J Digit Health 2024;5:670-682 Go to original source... Go to PubMed...
    10. White KS. Cardiovascular disease and anxiety. In: Anxiety in health behaviors and physical illness. New York, NY: Springer New York, 2008:279-315. Go to original source...
    11. Gao J, Liu Y, Li YM. Review of risk factors, treatment, and prevention of saphenous vein graft disease after coronary artery bypass grafting. J Int Med Res 2018;46:4907-4919. Go to original source...
    12. Sawma T, Arghami A, Schaff HV, et al. Risk Stratification of CABG Patients Using an Artificial Intelligence ECG-Derived Age. J Thorac Cardiovasc Surg 2026;171:201.e3-209.e3. Go to original source...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content